The EU Action Plan on Drugs (2005-2008) calls for member states of the European Union to provide information on five key epidemiological indicators. These are: general population surveys, prevalence and patterns of problem drug use, drug related infectious diseases, drug related deaths and mortality of drug users, and demand for drug treatment. The goal is to improve the comparability of data across the Member States, which is a central task of the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction). Ireland has made progress on a national level in meeting this obligation. Currently the core information systems used to monitor the drugs problem in Ireland and to inform policy making are in the health and law enforcement areas including treatment, mortality and crime data. The dominance of such objective indicators and treatment outcome measures has contributed to obscuring the view of communities experiencing drugs problems on a day to day basis. The data are summations of the individual experience of drug problems and contribute little to understanding the broader question of how drug problem effect communities. This article draws on a community drugs study to review the contribution of traditional indicators of drug problems and consider some of the limitations of this data. It then presents an analysis of community data to identify possible community indicators of drug problems.